Public sector supplier

Glenmark Pharmaceuticals Europe Limited public sector contracts

Glenmark Pharmaceuticals Europe Limited appears as a named supplier on 21 UK public sector contracts awarded since 2021.

1 of those were awarded in the last twelve months.

Its most frequent public sector customer is NHS England, with 14 contracts, and it has supplied 4 buying organisations in total.

Watch this competitorSee their contracts come up for renewal. 30 days free.
1
Contracts, last 12 months
21
Contracts since 2021
4
Public sector buyers
Not stated
Median contract won outright
1
Expiring in 18 months

These figures count published award notices from January 2021 onward, the point at which this database begins, and are comprehensive only from 2023. Contracts awarded before then, and any work not published as a public award notice, do not appear. This is a record of published contracts, not of turnover. Most recent award recorded 27 Aug 2026.

Coming up for renewal

1 contract expiring in the next 18 months

Each of these is a contract Glenmark Pharmaceuticals Europe Limited currently holds with an end date already published. If you compete with them, this is where the openings are. If you are the buyer, it is your renewal diary.

ContractBuyerValueExpires
NHS National Generic Pharmaceuticals Wave 14c (CF Award - Part 1)NHS England£1(shared, 63 suppliers)31 May 2027

Overview

Most of that work falls under medical equipment and pharmaceuticals.

0 of these were awarded to it as the only named supplier; the remaining 21 are contracts shared with other suppliers, typically a place on a framework rather than work awarded outright.

Contract values are not published on most of these notices.

1 of its contract is due to end within the next eighteen months.

Contracts won per quarter

Q3 241Q1 251Q3 261

Recent activity

Latest contracts won

ContractBuyerValueAwarded
Lot 2 - CM/PHG/24/2714/02 Hospital Only products DLN & DNW regionsNHS England£393.3m(shared, 101 suppliers)27 Aug 2026
NHS Framework Agreement for Branded Medicines - Proprietary Category TenderNHS England£1.2bn(shared, 72 suppliers)24 Mar 2025
NHS National Framework for Transition products commencing 1 October 2024NHS England£16.2m(shared, 12 suppliers)30 Sept 2024
NHS National Framework for Transition products commencing 1 May 2024NHS ENGLAND£7.6m(shared, 12 suppliers)16 Apr 2024
NHS Framework Agreement for Branded Medicines - National Tender - 1 May 2024NHS England£1.0bn(shared, 90 suppliers)5 Apr 2024
NHS National Generic Pharmaceuticals Wave 14c (CF Award - Part 1)NHS England£1(shared, 63 suppliers)4 Mar 2024
NHS National Generic Pharmaceuticals Wave 14bATAMIS LTD£428.2m(shared, 99 suppliers)7 Jul 2023
NHS Framework Agreement-Branded Medicines - National Proprietary PharmaceuticalsNHS England£304.5m(shared, 50 suppliers)24 Apr 2023
NHS National Generic Pharmaceuticals Wave 14aNHS England£208.0m(shared, 99 suppliers)14 Dec 2022
NHS National Pharmaceuticals Transition 2022_2NHS England£35.7m(shared, 18 suppliers)1 Nov 2022
NHS National Generic Pharmaceuticals - LenalidomideNHS England£1(shared, 14 suppliers)31 Aug 2022
NHS National Pharmaceuticals Transition 2022_1NHS England and NHS Improvement£39.6m(shared, 42 suppliers)19 Jul 2022
NHS National Pharmaceuticals Transition 2022_1NHS England and NHS Improvement£39.6m(shared, 42 suppliers)19 Jul 2022
NHS Framework Agreement for Branded medicines - NationalNHS England£526.0m(shared, 86 suppliers)16 May 2022
NHS Framework Agreement for Branded medicines - NationalNHS England£526.0m(shared, 86 suppliers)16 May 2022
National Procurement for HIV and Preventative TreatmentsNHSE&I£230.0m(shared, 15 suppliers)1 Feb 2022
NHS National Generic Pharmaceuticals Wave 13ATAMIS LTD£469.7m(shared, 99 suppliers)30 Nov 2021
NHS National Generic Pharmaceuticals Wave 13ATAMIS LTD£469.7m(shared, 99 suppliers)30 Nov 2021
NHS National Generic Pharmaceuticals Wave 13ATAMIS LTD£469.7m(shared, 100 suppliers)30 Nov 2021
NHS National Pharmaceuticals Transition 2021_3NHS England£26.0m(shared, 36 suppliers)22 Oct 2021

Where a contract names more than one supplier it is usually a framework. The published value is the ceiling for the whole framework, shared by everyone on it, not the amount awarded to Glenmark Pharmaceuticals Europe Limited.

Who they supply

Most frequent buyers

  1. 01NHS England14 contracts
  2. 02ATAMIS LTD4 contracts
  3. 03NHS England and NHS Improvement2 contracts
  4. 04NHSE&I1 contract

What they supply

Most active categories

Competing with Glenmark Pharmaceuticals Europe Limited?

Track the buyers they supply and get every new notice scored against your profile before 9am, alongside the contracts they hold that are coming up for renewal.

30 days free. No card required.

Common questions

Glenmark Pharmaceuticals Europe Limited, in short

Which public sector organisations does Glenmark Pharmaceuticals Europe Limited supply?

Across 21 contracts recorded since 2021, Glenmark Pharmaceuticals Europe Limited has supplied 4 UK public sector buyers. The most frequent are NHS England (14 contracts), ATAMIS LTD (4 contracts), NHS England and NHS Improvement (2 contracts).

What does Glenmark Pharmaceuticals Europe Limited supply to the public sector?

Its contracts fall mainly under medical equipment and pharmaceuticals. Categories are derived from the CPV codes published on each award notice.

How many public sector contracts has Glenmark Pharmaceuticals Europe Limited won?

21 since 2021, of which 0 were awarded to it as the only named supplier and 21 are shared with other suppliers, usually a place on a framework. This counts award notices published to Find a Tender and Contracts Finder, so it is a record of published awards rather than of total revenue.

When do Glenmark Pharmaceuticals Europe Limited contracts come up for renewal?

1 contract held by Glenmark Pharmaceuticals Europe Limited have an end date within the next 18 months, the earliest on 31 May 2027. End dates are published in the original award notices, so they are visible well before any re-tender is advertised.

Where does this information about Glenmark Pharmaceuticals Europe Limited come from?

From contract award notices published by the buyers themselves to Find a Tender and Contracts Finder under the Open Government Licence. Coverage starts in 2021 and is comprehensive from 2023, so contracts awarded before then, and any award not published to those portals, will not appear.

Contract data on this page is sourced from Find a Tender and Contracts Finder and published under the Open Government Licence v3.0. Contains public sector information licensed under that licence. Figures cover contract award notices published from January 2021 onward, with comprehensive coverage from 2023. Earlier contracts, and any award not published to Find a Tender or Contracts Finder, will not appear. This page describes contracts published by public bodies and is not affiliated with Glenmark Pharmaceuticals Europe Limited.

How to cite this data

Tender Radar (2026) Glenmark Pharmaceuticals Europe Limited public sector contracts [Dataset]. Professor AI. Available at: https://tender-radar.co.uk/suppliers/glenmark-pharmaceuticals-europe-limited (Accessed: 7 October 2026).

The figures change as notices are published, so the citation carries the date you read them.